MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617077119 A) filed by Danatlas Pharmaceuticals Co. , Ltd. on June 22, 2026, for Combination Of Polq Inhibitor And Anti-Cancer Therapeutic Agent.
Inventors include Zhou, Wenlai; Zhuo, Jincong; Yan, Dan; Chen, Huixian; Wang, Bin; and Zhang, Yan.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: Provided herein are combination therapies, and methods of treating diseases and/or conditions with combination therapies; wherein the combination can include PolQ inhibitor and a second anti-cancer therapeutic agent; and the PolQ inhibitor is represented by the compounds of Formula (I).
Disclaimer: Curated by HT Syndication.
